Save your place

Sign in to WhoBought

Please try again later.

Alnylam Pharmaceuticals, Inc. (ALNY) institutional ownership

Latest close $272.67 Jul 20, 2026
Market cap$46.1B 52-week range SectorHealthcare
Funds holding · Q1 2026
820
reported ALNY position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Net sold $237M
416 buyers · 404 sellers

Alnylam Pharmaceuticals, Inc. (ALNY) price and institutional activity

Dates

Q1 2026

$6.0B bought by 416 investors
T. Rowe Price Investment Management, Inc.$1.2BCapital Research Global Investors$916M +414 more
$6.2B sold by 404 investors
Capital World Investors-$1.9BNorges-$766M +402 more
Sign in to see who bought
Bought Sold Totals per quarter; hover a bar for the names.

Alnylam Pharmaceuticals, Inc. (ALNY) institutional activity · 820

Investor Type Est. change Change Δ Own Date
Capital World Investors · Reduced −$1.9B
Change −5.5M Date Q1 2026
Capital World Investors Reduced· Q1 2026 −$1.9B −5.5M Q1 2026
T. Rowe Price Investment Management, Inc. · Added +$1.2B
Change +3.4M Date Q1 2026
T. Rowe Price Investment Management, Inc. Added· Q1 2026 +$1.2B +3.4M Q1 2026
Capital Research Global Investors · Added +$916M
Change +2.7M Δ Own +39.7% Date Q1 2026
Capital Research Global Investors Added· Q1 2026 +$916M +2.7M +39.7% Q1 2026
Norges · Exited −$766M
Change −2.3M Δ Own −100.0% Date Q1 2026
Norges Exited· Q1 2026 −$766M −2.3M −100.0% Q1 2026
JPMorgan Chase & Co · Added +$546M
Change +1.6M Date Q1 2026
JPMorgan Chase & Co Added· Q1 2026 +$546M +1.6M Q1 2026
Two Sigma Investments, LP · Added +$468M
Change +1.4M Δ Own +223.4% Date Q1 2026
Two Sigma Investments, LP Added· Q1 2026 +$468M +1.4M +223.4% Q1 2026
FMR LLC · Reduced −$450M
Change −1.3M Δ Own −8.3% Date Q1 2026
FMR LLC Reduced· Q1 2026 −$450M −1.3M −8.3% Q1 2026
Two Sigma Advisers, LP · Exited −$385M
Change −1.1M Δ Own −100.0% Date Q1 2026
Two Sigma Advisers, LP Exited· Q1 2026 −$385M −1.1M −100.0% Q1 2026
Arrowstreet Capital, Limited Partnership · Exited −$383M
Change −1.1M Δ Own −100.0% Date Q1 2026
Arrowstreet Capital, Limited Partnership Exited· Q1 2026 −$383M −1.1M −100.0% Q1 2026
Invesco Ltd. · Reduced −$297M
Change −874K Δ Own −40.4% Date Q1 2026
Invesco Ltd. Reduced· Q1 2026 −$297M −874K −40.4% Q1 2026
Clearbridge Investments, LLC · Added +$258M
Change +759K Date Q1 2026
Clearbridge Investments, LLC Added· Q1 2026 +$258M +759K Q1 2026
D. E. Shaw & Co., Inc. · Added +$209M
Change +615K Δ Own +138.3% Date Q1 2026
D. E. Shaw & Co., Inc. Added· Q1 2026 +$209M +615K +138.3% Q1 2026
Manufacturers Life Insurance Company, the · Added +$204M
Change +599K Date Q1 2026
Manufacturers Life Insurance Company, the Added· Q1 2026 +$204M +599K Q1 2026
Marshall Wace, LLP · Added +$187M
Change +549K Date Q1 2026
Marshall Wace, LLP Added· Q1 2026 +$187M +549K Q1 2026
1832 Asset Management L.P. · Exited −$150M
Change −440K Δ Own −100.0% Date Q1 2026
1832 Asset Management L.P. Exited· Q1 2026 −$150M −440K −100.0% Q1 2026
Data through Q1 2026 · filed Jun 3, 2026
15 of 820

Famous investor activity in Alnylam Pharmaceuticals, Inc. (ALNY)

Alnylam Pharmaceuticals, Inc. (ALNY) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Pyott David E. I. · Director 5 operations −$1.1M
Price $297.71–$302.65 Qty −4K Owned 2K Trade date Jun 1, 2026 Filed date Jun 3, 2026
Pyott David E. I. Director 5 operations $297.71–$302.65 −4K −$1.1M 2K Jun 1, 2026 Jun 3, 2026
Pyott David E. I. · Director 2 operations 0
Owned 0 Trade date Jun 1, 2026 Filed date Jun 3, 2026
Pyott David E. I. Director 2 operations 0 0 Jun 1, 2026 Jun 3, 2026
Cravatt Benjamin · Director Grant (A) 4K
Owned 4K Trade date Jun 1, 2026 Filed date Jun 3, 2026
Cravatt Benjamin Director Grant (A) 4K 4K Jun 1, 2026 Jun 3, 2026
Sigal Charles Elliott · Director 2 operations 2K
Owned 1K Trade date May 20, 2026 Filed date May 22, 2026
Sigal Charles Elliott Director 2 operations 2K 1K May 20, 2026 May 22, 2026
Schulman Amy W. · Director 2 operations 3K
Owned 2K Trade date May 20, 2026 Filed date May 22, 2026
Schulman Amy W. Director 2 operations 3K 2K May 20, 2026 May 22, 2026
Reitan Colleen F. · Director 2 operations 2K
Owned 1K Trade date May 20, 2026 Filed date May 22, 2026
Reitan Colleen F. Director 2 operations 2K 1K May 20, 2026 May 22, 2026
Pyott David E. I. · Director 2 operations 2K
Owned 1K Trade date May 20, 2026 Filed date May 22, 2026
Pyott David E. I. Director 2 operations 2K 1K May 20, 2026 May 22, 2026
Kellogg Peter N. · Director 2 operations 2K
Owned 1K Trade date May 20, 2026 Filed date May 22, 2026
Kellogg Peter N. Director 2 operations 2K 1K May 20, 2026 May 22, 2026
Hamburg Margaret A. · Director 2 operations 2K
Owned 1K Trade date May 20, 2026 Filed date May 22, 2026
Hamburg Margaret A. Director 2 operations 2K 1K May 20, 2026 May 22, 2026
Brandicourt Olivier · Director 2 operations 2K
Owned 1K Trade date May 20, 2026 Filed date May 22, 2026
Brandicourt Olivier Director 2 operations 2K 1K May 20, 2026 May 22, 2026
Ausiello Dennis A. · Director 2 operations 2K
Owned 1K Trade date May 20, 2026 Filed date May 22, 2026
Ausiello Dennis A. Director 2 operations 2K 1K May 20, 2026 May 22, 2026
Arbuckle Stuart A. · Director 2 operations 2K
Owned 1K Trade date May 20, 2026 Filed date May 22, 2026
Arbuckle Stuart A. Director 2 operations 2K 1K May 20, 2026 May 22, 2026
Schulman Amy W. · Director 2 operations 0
Price $70.20 Owned 0 Trade date May 13, 2026 Filed date May 14, 2026
Schulman Amy W. Director 2 operations $70.20 0 0 May 13, 2026 May 14, 2026
McLaughlin Melissa · Officer 5 operations −$755K
Price $320.14–$333.94 Qty −2K Owned 9K Trade date Apr 6, 2026 Filed date Apr 7, 2026
McLaughlin Melissa Officer 5 operations $320.14–$333.94 −2K −$755K 9K Apr 6, 2026 Apr 7, 2026
McLaughlin Melissa · Officer 9 operations −$519K
Price $316.61–$325.49 Qty −2K Owned 12K Trade date Apr 2, 2026 Filed date Apr 7, 2026
McLaughlin Melissa Officer 9 operations $316.61–$325.49 −2K −$519K 12K Apr 2, 2026 Apr 7, 2026
15 of 54
15 of 54 Sign in to continue to older insider transactions.

Alnylam Pharmaceuticals, Inc. (ALNY) activist and large shareholders

What are Schedules 13D and 13G?

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Capital World Investors 16.4M
% of shares outstanding 13.1% Filing date Feb 9, 2024
Capital World Investors 16.4M 13.1% Feb 9, 2024
FMR LLC 14.8M
% of shares outstanding 11.5% Filing date Nov 12, 2024
FMR LLC 14.8M 11.5% Nov 12, 2024
FMR LLC 14.6M
% of shares outstanding 11.0% Filing date May 6, 2026
FMR LLC 14.6M 11.0% May 6, 2026
Vanguard Group Inc 11.9M
% of shares outstanding 9.5% Filing date Feb 13, 2024
Vanguard Group Inc 11.9M 9.5% Feb 13, 2024
Capital World Investors 10.9M
% of shares outstanding 8.2% Filing date May 14, 2026
Capital World Investors 10.9M 8.2% May 14, 2026
Capital Research Global Investors 9.5M
% of shares outstanding 7.1% Filing date May 14, 2026
Capital Research Global Investors 9.5M 7.1% May 14, 2026
BlackRock Inc. 8.5M
% of shares outstanding 6.8% Filing date Jan 26, 2024
BlackRock Inc. 8.5M 6.8% Jan 26, 2024
Vanguard Capital Management LLC 7.1M
% of shares outstanding 5.3% Filing date Apr 29, 2026
Vanguard Capital Management LLC 7.1M 5.3% Apr 29, 2026
8 of 11

Alnylam Pharmaceuticals, Inc. (ALNY) ownership FAQ

Who owns ALNY?

820 reporting institutions disclosed ALNY position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.